ÂÜÀòÂÒÂ×

Susie is an internationally recognized physician/scientist and strategic thinker with over 20 years of experience in clinical and translational research dedicated to improving the lives of patients. As an accomplished biopharmaceutical executive, Susie brings to her role as Chief Medical Officer at Arsenal Bio a proven track record of building and leading diverse teams of talented people who have successfully delivered novel and life altering therapies.

Prior to joining Arsenal Bio, Susie served as Chief Development Officer at Allogene Therapeutics, a clinical stage company pioneering the development of allogeneic CAR T cell therapy. Susie has also served as Vice President, Head of Development for Abbvie-Stemcentrx and led the Companion Diagnostics Center of Excellence at Abbvie. Prior to Abbvie, Susie served in senior roles at Gilead and Amgen, leading the development of innovative oncology and hematology programs such as XGEVA®, Nplate® and BLINCYTO®.

Susie received her M.D. from The University of Michigan Medical School, and her Ph.D. from The Rockefeller University. She completed her internal medicine training at Parkland Memorial Hospital, UT-Southwestern Medical Center, and her medical oncology and hematology training at Memorial Sloan Kettering Cancer Center in New York City. Susie is a founding member of the Chicago chapter of Chief, an organization dedicated to supporting, empowering and mentoring women C-suite leaders.